Total Payments
$176,549
2024 Payments
$386.32
Companies
13
Transactions
244
Medicare Patients
919
Medicare Billing
$142,062
Payment Breakdown by Category
Other$89,322 (50.6%)
Consulting$52,829 (29.9%)
Travel$27,782 (15.7%)
Food & Beverage$6,118 (3.5%)
Education$498.78 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,138 | 39 | 44.8% |
| Consulting Fee | $52,829 | 16 | 29.9% |
| Travel and Lodging | $27,782 | 63 | 15.7% |
| Honoraria | $10,184 | 5 | 5.8% |
| Food and Beverage | $6,118 | 114 | 3.5% |
| Education | $498.78 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $129,863 | 167 | $0 (2022) |
| Eli Lilly and Company | $18,736 | 30 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $14,755 | 9 | $0 (2021) |
| Horizon Therapeutics plc | $5,578 | 8 | $0 (2023) |
| Horizon Pharma plc | $4,896 | 1 | $0 (2018) |
| ABBVIE INC. | $655.80 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $653.00 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $549.62 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $255.07 | 3 | $0 (2024) |
| Genentech USA, Inc. | $200.00 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $386.32 | 7 | AstraZeneca Pharmaceuticals LP ($146.61) |
| 2023 | $534.65 | 5 | ABBVIE INC. ($228.65) |
| 2022 | $8,503 | 21 | Lilly USA, LLC ($8,041) |
| 2021 | $10,635 | 8 | Lilly USA, LLC ($7,788) |
| 2020 | $21,859 | 32 | Lilly USA, LLC ($15,453) |
| 2019 | $65,970 | 99 | Lilly USA, LLC ($42,132) |
| 2018 | $49,504 | 56 | Lilly USA, LLC ($38,961) |
| 2017 | $19,157 | 16 | Lilly USA, LLC ($17,488) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $44.08 | General |
| Category: Dermatology | ||||||
| 08/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Dermatology | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $122.67 | General |
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.94 | General |
| 05/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $70.31 | General |
| Category: Dermatology | ||||||
| 04/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $113.86 | General |
| Category: KRYSTEXXA | ||||||
| 11/12/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $108.46 | General |
| 04/20/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $83.68 | General |
| Category: Dermatology | ||||||
| 03/01/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $118.10 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $110.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $105.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $37.30 | General |
| Category: KRYSTEXXA | ||||||
| 10/05/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $117.23 | General |
| 09/21/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $78.95 | General |
| Category: IMMUNOLOGY | ||||||
| 08/11/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 08/03/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $78.70 | General |
| Category: Immunology | ||||||
| 07/20/2022 | Lilly USA, LLC | TALTZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: Immunology | ||||||
| 07/14/2022 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $610.00 | General |
| 07/14/2022 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $195.00 | General |
| 07/14/2022 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $195.00 | General |
| 07/14/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $70.00 | General |
| 07/14/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 07/14/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $45.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 222 | 356 | $108,166 | $33,751 |
| 2022 | 6 | 236 | 329 | $116,383 | $37,307 |
| 2021 | 5 | 225 | 369 | $110,019 | $40,865 |
| 2020 | 8 | 236 | 381 | $96,218 | $30,139 |
Total Patients
919
Total Services
1,435
Medicare Billing
$142,062
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 239 | $71,715 | $22,644 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 48 | $20,274 | $6,040 | 29.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $7,760 | $2,590 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,710 | $1,483 | 31.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 18 | $2,917 | $974.41 | 33.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 24 | $790.00 | $20.45 | 2.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 181 | $55,057 | $17,590 | 31.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 48 | 72 | $30,600 | $9,528 | 31.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $8,840 | $3,094 | 35.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $8,334 | $2,906 | 34.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 23 | 29 | $8,825 | $2,837 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $4,727 | $1,353 | 28.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 129 | 253 | $67,889 | $25,356 | 37.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 33 | 48 | $17,440 | $6,997 | 40.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $12,094 | $4,000 | 33.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 20 | 25 | $6,617 | $2,325 | 35.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $5,979 | $2,187 | 36.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 117 | 223 | $57,311 | $17,580 | 30.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 30 | 30 | $11,670 | $3,880 | 33.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 28 | $9,660 | $3,024 | 31.3% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2020 | 25 | 30 | $7,920 | $2,660 | 33.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 13 | $3,341 | $1,101 | 33.0% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 11 | 22 | $3,600 | $1,024 | 28.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 12 | 14 | $2,464 | $778.60 | 31.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 11 | 21 | $252.00 | $91.21 | 36.2% |
About Dr. Anthony Reginato, MD
Dr. Anthony Reginato, MD is a Rheumatology healthcare provider based in E. Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134195043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Reginato, MD has received a total of $176,549 in payments from pharmaceutical and medical device companies, with $386.32 received in 2024. These payments were reported across 244 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,138).
As a Medicare-enrolled provider, Reginato has provided services to 919 Medicare beneficiaries, totaling 1,435 services with total Medicare billing of $142,062. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location E. Providence, RI
- Active Since 02/28/2006
- Last Updated 10/12/2016
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1134195043
Products in Payments
- TALTZ (Drug) $106,276
- TREMFYA (Drug) $8,349
- Tremfya (Drug) $6,505
- KRYSTEXXA (Biological) $5,578
- OLUMIANT (Drug) $5,323
- KRYSTEXXA (Drug) $4,896
- STELARA (Biological) $554.00
- COSENTYX (Biological) $326.23
- RINVOQ (Biological) $302.35
- COSENTYX (Drug) $223.39
- Rituxan (Biological) $200.00
- Otezla (Drug) $167.50
- SKYRIZI (Biological) $128.95
- XELJANZ (Drug) $121.93
- Humira (Biological) $117.89
- HUMIRA (Biological) $106.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.